Global C-Reactive Protein Testing Market is valued at USD 5.30 billion in 2025 to around USD 6.02 billion by 2034, with CAGR of approximately 1.43% during the forecast period. Scope of C-Reactive Protein Testing Market The C-Reactive Protein Testing are the diagnostic solutions used to measure CRP levels in blood, a key biomarker of inflammation and infection. CRP testing is widely used to assess acute and chronic inflammatory conditions, cardiovascular disease risk, autoimmune disorders, and post-surgical complications. Its applications span hospitals, diagnostic laboratories, research institutions, and point-of-care (POC) settings.